THELMA Therapeutics Co., Ltd.

KOSE:A015540 Stock Report

Market Cap: ₩4.4b

THELMA Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Lee Kyu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure8.7yrs

Recent management updates

Recent updates


CEO

Lee Kyu

no data

Tenure

Lee Yil Kyu serves as the Chief Executive Officer at THELMA Therapeutics Co., Ltd. (formerly known as Medipartner Biotechnology. Co., Ltd.)


Board Members

NamePositionTenureCompensationOwnership
Park Hee
Executive Director9.7yrsno datano data
Jong Park
Executive Director9.7yrsno datano data
Jeong Seo
Executive Director8.7yrsno datano data
Jae Oh
Executive Director8.7yrsno datano data
Cho Ho Gyeon
Executive Director8.7yrsno datano data
Jun Cho
Executive Director8.1yrsno datano data
Ji Yoo
Non-Executive Director8.7yrsno datano data
Yeon Cho
Non-Executive Director9.7yrsno datano data

8.7yrs

Average Tenure

Experienced Board: A015540's board of directors are considered experienced (8.7 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.